Predict your next investment

HEALTHCARE | Drug Discovery
januxrx.com

See what CB Insights has to offer

Founded Year

2017

Stage

IPO | IPO

Total Raised

$192.44M

Date of IPO

6/11/2021

Market Cap

0.76B

Stock Price

18.63

About Janux Therapeutics

Janux Therapeutics (NASDAQ: JANX) develops T-cell engager bispecifics that combine tumor-specific activation with improved PK.

Janux Therapeutics Headquarter Location

11099 North Torrey Pines Park Road Suite 290

La Jolla, California, 92037,

United States

Latest Janux Therapeutics News

Janux Therapeutics Reports Business Highlights and Third Quarter 2021 Financial Results

Nov 9, 2021

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today reported financial results for the quarter ended September 30, 2021. “In the third quarter, we continued to utilize our novel TRACTr and TRACIr platforms to advance our pipeline of next generat

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Janux Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Janux Therapeutics is included in 3 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Janux Therapeutics Patents

Janux Therapeutics has filed 3 patents.

The 3 most popular patent topics include:

  • Immune system
  • Immunology
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/6/2018

Immunology, Immune system, T cells, Clusters of differentiation, Human cells

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/6/2018

00/00/0000

00/00/0000

Grant Date

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Immunology, Immune system, T cells, Clusters of differentiation, Human cells

Subscribe to see more

Subscribe to see more

Status

Application

Subscribe to see more

Subscribe to see more

Janux Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Janux Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.